503A vs. 503B: A Quick Guide to Compounding Pharmacy Designations & Regulations peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC157 Legal? WADA, FDA Status, and What You Need to Know BPC 157 Banned: Key Facts on the Latest FDA Decision